- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.30 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x NAG- FUC- NAG: alpha-L-fucopyranose-(1-3)-[2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG- BMA- FUC: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-3)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG- BMA- MAN- MAN- FUC: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-3)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- FUC: alpha-L-fucopyranose-(1-3)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x ZN: ZINC ION(Non-covalent)
- 2 x FE: FE (III) ION(Non-covalent)
FE.7: 6 residues within 4Å:- Chain A: D.129, D.158, Y.161, H.319
- Ligands: ZN.6, MFJ.20
4 PLIP interactions:4 interactions with chain A- Metal complexes: A:D.129, A:D.158, A:Y.161, A:H.319
FE.22: 6 residues within 4Å:- Chain B: D.129, D.158, Y.161, H.317, H.319
- Ligands: ZN.21
4 PLIP interactions:4 interactions with chain B- Metal complexes: B:D.129, B:D.158, B:Y.161, B:H.319
- 3 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.8: 6 residues within 4Å:- Chain A: M.5, D.10, V.11, F.134, N.137, S.141
6 PLIP interactions:6 interactions with chain A- Hydrogen bonds: A:D.10, A:D.10, A:N.137, A:S.141, A:R.182
- Water bridges: A:E.144
NAG.23: 7 residues within 4Å:- Chain B: M.5, S.9, D.10, V.11, F.134, N.137, S.141
4 PLIP interactions:4 interactions with chain B- Hydrogen bonds: B:D.10, B:D.10, B:N.137, B:S.141
NAG.25: 2 residues within 4Å:- Chain B: N.75, N.167
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:N.75, B:N.167
- 7 x SO4: SULFATE ION(Non-functional Binders)
SO4.9: 3 residues within 4Å:- Chain A: Q.368, Q.370, R.377
5 PLIP interactions:5 interactions with chain A- Hydrogen bonds: A:Q.368, A:Q.370
- Water bridges: A:Q.370, A:Q.370
- Salt bridges: A:R.377
SO4.10: 3 residues within 4Å:- Chain A: K.268, R.269, S.270
5 PLIP interactions:5 interactions with chain A- Hydrogen bonds: A:R.269, A:S.270
- Water bridges: A:V.267
- Salt bridges: A:K.268, A:H.418
SO4.11: 5 residues within 4Å:- Chain A: S.55, N.58, R.62, Y.95
- Ligands: NA.14
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:S.55, A:N.58
- Salt bridges: A:R.62
SO4.12: 1 residues within 4Å:- Chain A: R.400
1 PLIP interactions:1 interactions with chain A- Salt bridges: A:R.400
SO4.26: 4 residues within 4Å:- Chain A: E.293
- Chain B: R.252, Y.257, K.300
8 PLIP interactions:2 interactions with chain A, 6 interactions with chain B- Water bridges: A:M.292, A:E.293, B:R.252, B:R.252
- Hydrogen bonds: B:Y.257, B:Y.257
- Salt bridges: B:R.252, B:K.300
SO4.27: 3 residues within 4Å:- Chain B: K.268, R.269, S.270
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:R.269, B:S.270, B:S.270
SO4.28: 3 residues within 4Å:- Chain B: R.34, Y.91, Q.115
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:Y.91, B:Q.115
- Salt bridges: B:R.34
- 3 x NA: SODIUM ION(Non-functional Binders)
NA.13: 4 residues within 4Å:- Chain A: G.251, R.252, K.300
- Chain B: E.293
4 PLIP interactions:2 interactions with chain A, 2 interactions with chain B- Hydrogen bonds: A:R.252, A:K.300, B:E.293
- Water bridges: B:S.281
NA.14: 6 residues within 4Å:- Chain A: W.54, S.55, G.59, R.60, R.62
- Ligands: SO4.11
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:S.55, A:S.55, A:R.60
NA.29: 4 residues within 4Å:- Chain A: E.293
- Chain B: G.251, R.252, K.300
4 PLIP interactions:1 interactions with chain A, 3 interactions with chain B- Water bridges: A:E.293
- Hydrogen bonds: B:R.252, B:K.300, B:K.300
- 7 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.15: 1 residues within 4Å:- Chain A: P.147
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:P.147
EDO.16: 6 residues within 4Å:- Chain A: T.299, N.329, I.330, Y.332
- Chain B: M.292, E.295
4 PLIP interactions:3 interactions with chain A, 1 interactions with chain B- Hydrogen bonds: A:T.299, A:N.329, A:Y.332
- Water bridges: B:E.295
EDO.17: 4 residues within 4Å:- Chain A: Y.359
- Ligands: PGE.19, MFJ.20, PGE.36
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:Y.359, A:Y.359
EDO.24: 3 residues within 4Å:- Chain B: S.214, Y.215, H.218
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:S.214
EDO.30: 3 residues within 4Å:- Chain B: G.253
- Ligands: MFJ.20, PGE.36
4 PLIP interactions:1 interactions with chain A, 3 interactions with chain B- Water bridges: A:N.195, B:R.252, B:G.253, B:G.253
EDO.31: 6 residues within 4Å:- Chain B: D.163, Y.165, P.166, N.167, H.168, E.203
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:Y.165, B:N.167, B:H.168
EDO.32: 6 residues within 4Å:- Chain A: M.292
- Chain B: T.299, N.329, I.330, A.331, Y.332
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:I.330, B:Y.332
- Water bridges: B:R.298
- 5 x PGE: TRIETHYLENE GLYCOL(Non-functional Binders)
PGE.18: 7 residues within 4Å:- Chain A: N.288, H.289, I.362, D.363, S.364, N.365
- Ligands: PGE.36
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:S.364, A:S.364, A:N.365
- Water bridges: A:H.289
PGE.19: 5 residues within 4Å:- Chain A: R.164, Y.359
- Ligands: EDO.17, MFJ.20, PGE.36
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:Y.359
PGE.34: 5 residues within 4Å:- Chain B: H.289, I.362, D.363, S.364, N.365
4 PLIP interactions:4 interactions with chain B- Hydrogen bonds: B:S.364, B:N.365, B:N.365
- Water bridges: B:H.289
PGE.35: 2 residues within 4Å:- Chain B: K.307, Y.308
2 PLIP interactions:2 interactions with chain B- Water bridges: B:K.307, B:K.309
PGE.36: 6 residues within 4Å:- Chain B: R.252
- Ligands: EDO.17, PGE.18, PGE.19, MFJ.20, EDO.30
1 PLIP interactions:1 interactions with chain B- Water bridges: B:R.252
- 1 x MFJ: [(R)-{[(2E,4Z,8Z)-dodeca-2,4,8-trien-1-yl]oxy}(naphthalen-1-yl)methyl]phosphonic acid(Non-covalent)
MFJ.20: 19 residues within 4Å:- Chain A: D.129, D.158, Y.161, R.164, N.195, H.196, H.289, H.290, E.293, H.317, H.319, Y.359
- Chain B: R.252
- Ligands: ZN.6, FE.7, EDO.17, PGE.19, EDO.30, PGE.36
5 PLIP interactions:4 interactions with chain A, 1 interactions with chain B- Hydrophobic interactions: A:R.164, B:R.252
- Hydrogen bonds: A:H.290
- pi-Stacking: A:H.289, A:H.290
- 1 x GOL: GLYCEROL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Feder, D. et al., Synthesis, evaluation and structural investigations of potent purple acid phosphatase inhibitors as drug leads for osteoporosis. Eur.J.Med.Chem. (2019)
- Release Date
- 2019-09-04
- Peptides
- Fe(3+)-Zn(2+) purple acid phosphatase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.30 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x NAG- FUC- NAG: alpha-L-fucopyranose-(1-3)-[2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG- BMA- FUC: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-3)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG- BMA- MAN- MAN- FUC: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-3)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- FUC: alpha-L-fucopyranose-(1-3)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x ZN: ZINC ION(Non-covalent)
- 2 x FE: FE (III) ION(Non-covalent)
- 3 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 7 x SO4: SULFATE ION(Non-functional Binders)
- 3 x NA: SODIUM ION(Non-functional Binders)
- 7 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 5 x PGE: TRIETHYLENE GLYCOL(Non-functional Binders)
- 1 x MFJ: [(R)-{[(2E,4Z,8Z)-dodeca-2,4,8-trien-1-yl]oxy}(naphthalen-1-yl)methyl]phosphonic acid(Non-covalent)
- 1 x GOL: GLYCEROL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Feder, D. et al., Synthesis, evaluation and structural investigations of potent purple acid phosphatase inhibitors as drug leads for osteoporosis. Eur.J.Med.Chem. (2019)
- Release Date
- 2019-09-04
- Peptides
- Fe(3+)-Zn(2+) purple acid phosphatase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
D